Cancer clinical trials in the region Bretagne

257 currently recruiting clinical trials
Region Bretagne
Phase 1 / Phase 2 Breast cancer Lung cancer Prostate cancer Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer #NCT06818643 #2024-516817-19-00
Locally Advanced Metastatic 1 2 3 or more
Systemic Treatment-Naive
3 recruiting sites
Merck Sharp & Dohme LLC
Phase 1 / Phase 2 Breast cancer Lung cancer Prostate cancer Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer #NCT05410145 #2023-508517-16-00
Locally Advanced Metastatic Metastatic Castration-resistant KRAS G12C 1 2 3 or more
Systemic Treatment-Naive
4 recruiting sites
D3 Bio (Wuxi) Co., Ltd
Phase 1 / Phase 2 Ovarian / Fallopian tubes / Peritoneum cancer #NCT06888921 #2025-521125-33-00
Epithelial ovarian cancer Fallopian tube cancer Primary peritoneal cancer (PPC) 2 3 or more Recurrence 6 months or more after platinum treatme... Chemotherapy Chemotherapy
Systemic Treatment-Naive Immunotherapy Systemic Treatment-Naive Immunotherapy
8 recruiting sites
Compugen Ltd
Phase 1 / Phase 2 Lung cancer #NCT06362252 #2023-509629-36-00
Cohorte 1 (Maintenance)
SCLC (Small Cell Lung Cancer) Metastatic None Immunotherapy Chemotherapy
8 recruiting sites
Daiichi Sankyo
Phase 1 / Phase 2 Colon cancer Rectal cancer #NCT06923761 #2023-504845-30-00
Module 2 Partie D cancer colorectal pMMR/MSS
Locally Advanced Metastatic MSS/pMMR 1 2 3 or more
Systemic Treatment-Naive
7 recruiting sites
Grey Wolf Therapeutics
Phase 1 / Phase 2 Stomach and esophageal cancer #NCT06780111 #2024-514273-22-00
Esophagus Squamous cell carcinoma Locally Advanced Metastatic None Systemic Treatment-Naive
Immunotherapy
3 recruiting sites
Merck Sharp & Dohme LLC
Phase 1 / Phase 2 Kidney cancer #NCT07049926 #2024-516437-12-00
Clear cell carcinoma Locally Advanced Metastatic None Immunotherapy Systemic Treatment-Naive
5 recruiting sites
Merck Sharp & Dohme LLC
Phase 1 / Phase 2 Pancreas cancer #NCT06885034 #2025-520672-26-00
Adenocarcinoma Locally Advanced Metastatic 1
Systemic Treatment-Naive
3 recruiting sites
GlaxoSmithKline
Phase 1 / Phase 2 Colon cancer Rectal cancer #NCT06885034 #2025-520672-26-00
Adenocarcinoma Locally Advanced Metastatic 1 2
Systemic Treatment-Naive
3 recruiting sites
GlaxoSmithKline